![Richard Markus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Markus
Hoofd Techniek/Wetenschap/O&O bij
ARCUS BIOSCIENCES, INC.
Vermogen: 285 270 $ op 30-06-2026
Profiel
Richard A. Markus is currently Chief Medical Officer at Arcus Biosciences, Inc. since 2025.
Formerly, Dr. Markus was President, Chief Executive Officer & Director at Dantari, Inc. from 2019 to 2024.
Dr. Markus also served as Senior Medical Director at Corus Pharma, Inc. and as Vice President-Global Development at Amgen, Inc. from 2011 to 2019.
Education includes undergraduate studies at the University of California, Los Angeles and a doctorate from the University of Southern California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2026 | 9.253 ( 0,01% ) | 285 270 $ | 30-06-2026 |
Actieve functies van Richard Markus
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 31-01-2025 |
Eerdere bekende functies van Richard Markus
| Bedrijven | Functie | Einde |
|---|---|---|
Dantari, Inc.
 Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Algemeen Directeur | 01-08-2024 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2019 |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Corporate Officer/Principal | - |
Opleiding van Richard Markus
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
88
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
